|
1
|
Smith-Bindman R, Lebda P, Feldstein VA,
Sellami D, Goldstein RB, Brasic N, Jin C and Kornak J: Risk of
thyroid cancer based on thyroid ultrasound imaging characteristics:
Results of a population-based study. JAMA Intern Med.
173:1788–1796. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Cabanillas ME, McFadden DG and Durante C:
Thyroid cancer. Lancet. 388:2783–2795. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Pellegriti G, Frasca F, Regalbuto C,
Squatrito S and Vigneri R: Worldwide increasing incidence of
thyroid cancer: Update on epidemiology and risk factors. J Cancer
Epidemiol. 2013:9652122013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Randle RW, Bushman NM, Orne J, Balentine
CJ, Wendt E, Saucke M, Pitt SC, Macdonald CL, Connor NP and Sippel
RS: Papillary thyroid cancer: The good and bad of the ‘good
cancer’. Thyroid. 27:902–907. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Karantza V: Keratins in health and cancer:
More than mere epithelial cell markers. Oncogene. 30:127–138. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Paiva F, Duarte-Pereira S, Costa VL,
Ramalho-Carvalho J, Patrício P, Ribeiro FR, Lobo F, Oliveira J,
Jerónimo C and Henrique R: Functional and epigenetic
characterization of the KRT19 gene in renal cell neoplasms. DNA
Cell Biol. 30:85–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Cen D, Chen J, Li Z, Zhao J and Cai X:
Prognostic significance of cytokeratin 19 expression in pancreatic
neuroendocrine tumor: A meta-analysis. PLoS One. 12:e01875882017.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Takano M, Shimada K, Fujii T, Morita K,
Takeda M, Nakajima Y, Nonomura A, Konishi N and Obayashi C: Keratin
19 as a key molecule in progression of human hepatocellular
carcinomas through invasion and angiogenesis. BMC Cancer.
16:9032016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Masai K, Nakagawa K, Yoshida A, Sakurai H,
Watanabe S, Asamura H and Tsuta K: Cytokeratin 19 expression in
primary thoracic tumors and lymph node metastases. Lung Cancer.
86:318–323. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ju JH, Oh S, Lee KM, Yang W, Nam KS, Moon
HG, Noh DY, Kim CG, Park G, Park JB, et al: Cytokeratin19 induced
by HER2/ERK binds and stabilizes HER2 on cell membranes. Cell Death
Differ. 22:665–676. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Edge SB and Compton CC: The American Joint
Committee on Cancer: the 7th edition of the AJCC cancer staging
manual and the future of TNM. Ann Surg Oncol. 17:1471–1474. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Li B and Dewey CN: RSEM: Accurate
transcript quantification from RNA-Seq data with or without a
reference genome. BMC Bioinformatics. 12:3232011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Subramanian A, Tamayo P, Mootha VK,
Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub
TR, Lander ES and Mesirov JP: Gene set enrichment analysis: A
knowledge-based approach for interpreting genome-wide expression
profiles. Proc Natl Acad Sci USA. 102:15545–15550. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Mootha VK, Lindgren CM, Eriksson KF,
Subramanian A, Sihag S, Lehar J, Puigserver P, Carlsson E,
Ridderstråle M, Laurila E, et al: PGC-1alpha-responsive genes
involved in oxidative phosphorylation are coordinately
downregulated in human diabetes. Nat Genet. 34:267–273. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ohtsuka T, Sakaguchi M, Yamamoto H, Tomida
S, Takata K, Shien K, Hashida S, Miyata-Takata T, Watanabe M,
Suzawa K, et al: Interaction of cytokeratin 19 head domain and HER2
in the cytoplasm leads to activation of HER2-Erk pathway. Sci Rep.
6:395572016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Saha SK, Choi HY, Kim BW, Dayem AA, Yang
GM, Kim KS, Yin YF and Cho SG: KRT19 directly interacts with
β-catenin/RAC1 complex to regulate NUMB-dependent NOTCH signaling
pathway and breast cancer properties. Oncogene. 36:332–349. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Stathopoulos EN, Sanidas E, Kafousi M,
Mavroudis D, Askoxylakis J, Bozionelou V, Perraki M, Tsiftsis D and
Georgoulias V: Detection of CK-19 mRNA-positive cells in the
peripheral blood of breast cancer patients with histologically and
immunohistochemically negative axillary lymph nodes. Ann Oncol.
16:240–246. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yang XR, Xu Y, Shi GM, Fan J, Zhou J, Ji
Y, Sun HC, Qiu SJ, Yu B, Gao Q, et al: Cytokeratin 10 and
cytokeratin 19: Predictive markers for poor prognosis in
hepatocellular carcinoma patients after curative resection. Clin
Cancer Res. 14:3850–3859. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Chen TF, Jiang GL, Fu XL, Wang LJ, Qian H,
Wu KL and Zhao S: CK19 mRNA expression measured by
reverse-transcription polymerase chain reaction (RT-PCR) in the
peripheral blood of patients with non-small cell lung cancer
treated by chemo-radiation: An independent prognostic factor. Lung
Cancer. 56:105–114. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Arcolia V, Journe F, Renaud F, Leteurtre
E, Gabius HJ, Remmelink M and Saussez S: Combination of galectin-3,
CK19 and HBME-1 immunostaining improves the diagnosis of thyroid
cancer. Oncol Lett. 14:4183–4189. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Cerami E, Gao J, Dogrusoz U, Gross BE,
Sumer SO, Aksoy BA, Jacobsen A, Byrne CJ, Heuer ML, Larsson E, et
al: The cBio cancer genomics portal: An open platform for exploring
multidimensional cancer genomics data. Cancer Discov. 2:401–404.
2012. View Article : Google Scholar : PubMed/NCBI
|
